Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terbutaline for Acute Tocolysis in Fetal Distress
NCT05326269Completed
- Sponsor
- Hospital Kemaman
- Start
- Apr 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of terbutaline in Non-reassuring fetal status (NRFHT) (2 arms), sponsored by Hospital Kemaman. Primary endpoint: Proportion of babies with neonatal acidosis at 1 hour. Started Apr 2017; status: completed.
02
Drugs
terbutaline
03
Conditions
Non-reassuring fetal status (NRFHT)
Beyond the preview
Go deeper on NCT05326269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05326269.